share_log
Benzinga ·  Mar 25 12:50
Mural Oncology Shares Are Trading Lower After the Company Announced It Will Discontinue Its Final Analysis of Nemvaleukin in Combination With KEYTRUDA and Will Cease Further Development. Jones Trading Downgraded the Stock From Buy to Hold
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 401

Recommended

Write a comment